Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across ...
Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine and the sole member of the type II interferon class. Originally referred to as macrophage-activating factor, IFN-γ is now recognized as ...
Inflammatory factors derived from adipose tissue have been implicated in mediating insulin resistance in obesity. We sought to identify these using explanted human adipose tissue exposed to innate and ...
Interferon, the "superhero" cure for viral infections, may be a strong weapon in the battle against fungal infections in immunocompromised patients, according to a new article. Fungal infections ...
A new study combining single-cell RNA sequencing from multiple renal cell carcinoma cohorts found that interferon-gamma ...
Boosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests. The work, led by a team in The ...
The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...
To study the use of interferon-gamma release assay (IFN-γ) (IGRAs) as a diagnostic test for tuberculosis (TB)-associated uveitis (TAU). All subjects underwent investigations to rule out underlying ...
Idiopathic pulmonary fibrosis (IPF) is a fatal disease for which no effective treatment exists. In this study—the INSPIRE trial—treatment with interferon gamma-1b (Ifn-g1b) is shown not to improve ...
ACROBiosystems — the leading producer of recombinant proteins and other vital reagents to encourage the development of target therapeutics, diagnostics, and vaccines — has established an antibody ...
T cells have long been studied for their ability to target and eliminate tumor cells. In order for the T cells to do so, the tumors must express antigens not presented by healthy tissues, and the ...
Interferon, the “superhero” cure for viral infections, may be a strong weapon in the battle against fungal infections in immunocompromised patients, according to an article in the November issue of ...